期刊文献+

核转录因子EBF3 mRNA在肝癌和食管癌组织中表达水平的研究

Study on Expression of Early B Cell Factor 3 mRNA in Tissues of Primary Hepatocellular and Esophageal Carcinoma
下载PDF
导出
摘要 目的研究核转录因子EBF3 mRNA在肝癌和食管癌组织中表达水平及其在肿瘤发生中的意义。方法肝及食管组织分别以β2微球蛋白(β2M)和18S rRNA为内参,实时荧光定量RT-PCR方法检测肝癌及食管癌及其远端组织中EBF3 mRNA的含量。结果18例肝癌和配对远端肝组织中EBF3 mRNA与β2M mRNA的对数比值分别为0.52±0.17和0.28±0.23,差异有统计学意义(t=3.56,P=0.0011)。12例食管癌和配对远端食管组织中EBF3 mRNA与18S rRNA的对数比值分别为0.58±0.054和0.22±0.24,差异有统计学意义(t=5.07,P=0.0000)。结论EBF3 mRNA在肝癌和食管癌组织中表达显著增高。核转录因子EBF3可能与肝和食管肿瘤的发生有关。 Objective To investigate the significance of early B-cell factor 3(EBF3) mRNA level in tissues of primary hepatocellular and esophageal carcinoma. Methods Amplification of 18S rRNA and β2 microgluobulin (β2M) were used as controls for RNA integrity for all tissue samples of liver and esophagus . The expression levels of EBF3 mRNA in liver and esophageal cancerous and their paired noncancerous tissues were determined by fluorescence quantitative real-time polymerase chain reaction(FQ-RT-PCR). Results The ratios of EBF3 mRNA to β2M mRNA in 18 liver cancerous tissues (0. 52±0. 17) were significantly higher than those in distant liver noncancerous tissues(0. 28±0. 23, t=3.56,P=0. 001 1). The ratios of EBF3 mRNA to 18S rRNA in 12 esophageal cancerous tissues (0. 58±0. 054) were significantly higher than those in distant esophageal noncancerous tissues(0. 22±0. 24,t=5.07,P=0. 000 0). Conclusion The results suggested that EBF3 mRNA may contribute to occurrence of primary hepatocellular and esophageal carcinoma.
出处 《现代检验医学杂志》 CAS 2008年第1期64-66,共3页 Journal of Modern Laboratory Medicine
关键词 早期B细胞因子3 实时荧光定量RT—PCR 肝肿瘤 食管肿瘤 early B-cell factor 3 FQ-RT-PCR liver neoplasms esophageal neoplasms
  • 相关文献

参考文献5

  • 1Hagman J,Travis A,Grosschedl R. A novel lineagespecific nuclear factor regulates mb-1 gene transcription at the early stages of B cell differentiation[J]. EMBO J, 1991,10(11 ) : 3409-3417.
  • 2Wang SS,Tsai RY,Reed RR. The characterization of the olf-1/EBF-like HLH transcription factor family: implications in olfactory gene regulation and neuronal development[J]. The Journal of Neurosclence, 1997,17(11) :4149-4158.
  • 3Zardo G, Tiirikainen MI, Hong C,et al. Integrated genomie and epigenomie analyses pinpoint biallelie gene inactivation in tumors[J].Nat Genet, 2002,32 (3) : 453-458.
  • 4Zhao LY,Niu Y,Santiago A,et al. An EBF3-mediated transcriptional program that induces cell cycle arrest and apoptosis[J].Cancer Res, 2006, 66 (19):9445-9452.
  • 5王燕,闻新棉,窦恒利,仲人前.自身免疫病患者增殖诱导配体基因mRNA表达水平的研究[J].临床检验杂志,2006,24(4):299-301. 被引量:3

二级参考文献8

  • 1Hahne M,Kataoka T,Schroter M,et al.APRIL,a new ligand of the tumor necrosis factor family,stimulates tumor cell growth[J].J Exp Med,1998,188(6):1185-1190.
  • 2Kolfschoten G,Balade B,Hahne M,et al.TWE-PRIL:a fusion protein of TWEAK and APRIL[J].Biochemical Pharmacology,2003,16(8):1427-1432.
  • 3Rennert P,Schneider P,Cachero T,et al.A soluble form of B cell maturation antigen,a receptor for the tumor necrosis factor family member APRIL,inhibits tumor cell growth[J].J Exp Med,2000,192(11):1677-1684.
  • 4Mackay F,Schneider P,Rennert P,et al.BAFF and APRIL:A tutorial on B cell survival[J].Annu Rev Immunol,2003,21(2):231-264.
  • 5Khare S D,Sarosi I,Xia X Z,et al.Severe B cell hyperplasia and autoimmune disease in TALL-Ⅰtransgenic mice[J].Proc Narl Acad Sci USA,2000,97(7):3370-3375.
  • 6Cheema G S,Roschke V,Baker K P,et al.Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic disease[J].Arthritis Rheum,2001,44(6):1313-1319.
  • 7Strasser A,Harris A W,Cory S.Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship[J].Cell,1991,67(5):889-899.
  • 8Castell R,Estelles A,Vazquez C,et al.Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator,plasminogen activator inhibitor type 1,and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer[J].Clin Chem,2002,48(8):1288-1295.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部